1 asset in Duplication/Inversion 15q11

Therapeutic assets addressing Duplication/Inversion 15q11, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)- Duplication/Inversion 15q11	Hospital Ruber Internacional	P4	BB (65)